Elliott S. Fisher

Last updated

Elliott S. Fisher is a health policy researcher and advocate for improving health system performance in the United States. He helped develop the concept of accountable care organizations and championed their adoption by Medicare. The development of the Affordable Care Act was influenced by his research on disparities in healthcare spending and utilization across the United States. He has strongly supported a rapid transition from fee-for-service to pay-for-performance models in the U.S. healthcare industry. [1] He is a tenured faculty member at Dartmouth College, where he teaches in the Masters in Public Health program.

Contents

Personal life and education

Fisher earned a BA from Harvard College in East Asia Studies in 1976; an MD from Harvard Medical School in 1981; and a MPH in health research from the University of Washington in 1985. He is the son of late Harvard academic Roger Fisher and brother of Peter R. Fisher.

Career

In 1986, Fisher became a member of the faculty at Dartmouth Medical School (now the Geisel School of Medicine), where he continues to teach. He also served as a physician at the Veterans Affairs Medical Center in White River Junction, Vermont, from 1986 to 2004.

Fisher served as the director of The Dartmouth Institute for Health Policy and Clinical Practice from 2013 through 2019 [2] and he served as the institute's Director of the Centers for Population Health and Healthy Policy Research from 2007 through 2009.

Early research on health system performance

A general internist, Fisher's early research focused on the promise and pitfalls of using of large databases, such as vital records, census data, and Medicare claims to study health care. [3]

In the last three decades, Fisher led studies that used claims data and other data sources to explore the causes and consequences of the dramatic differences in spending and utilization of health care across the country, research that revealed that the excess spending in high cost regions was largely due to overuse of discretionary—often avoidable—services and that higher utilization was not associated with better quality or health outcomes. He concluded that the United States is wasting a substantial portion of spending on avoidable and potentially harmful care. The landmark research was cited by Peter R. Orszag as President Barack Obama's administration crafted the Patient Protection and Affordable Care Act. [4] [5] [6] [7] [8] [9]

Accountable care organizations

In the mid-2000s, as consensus emerged that health costs were rising at an unsustainable rate and that fragmented, poorly coordinated care was a major problem, Fisher proposed a new payment and delivery model to encourage groups of physicians, with or without hospitals, to focus on improving quality and avoiding unnecessary expenditures. Fisher and Glen Hackbarth, chair of the Medicare Payment Advisory Commission, came up with the term "accountable care organization" (ACO) to describe the model. [10] [11] [12]

Fisher then worked with a small group of researchers and policy advocates, including Mark McClellan, to refine the design of the model and estimate the potential impact on spending. The goal of ACOs is to give systems financial incentives to be efficient and to keep patients out of the hospital. On January 18, 2011, the U.S. Department of Health and Human Services introduced guidelines for the ACO's inclusion in the new health care law. [13]

ReThink Health

In the mid-2000s, the Fannie E. Rippel Foundation convened a small group of thought leaders, including Donald Berwick, Elliott Fisher, Amory Lovins, Peter Senge and Elinor Ostrom, to consider the major barriers to reforming health care and improving health in the United States. [14] The group evolved into what is now a national program of the Rippel Foundation that has developed a computer simulation of local health care economies and partnership with the Robert Wood Johnson Foundation to catalyze local health system change. [15]

Research

Fisher's ongoing research is focused on evaluating how current delivery and payment system reforms contribute to improving the quality and cost of health care. He is the principal investigator of the Dartmouth-Berkeley Center of Excellence in Health Systems Performance. He and investigators from the Dartmouth Institute and the University of California, Berkeley, are examining the market and organizational factors that are associated with better health care—and with the successful formation of ACOs and other innovative models of care delivery. [16]

Recognition

In 2009, Fisher appeared on 60 Minutes in a segment titled "The Cost of Dying". He told host Steve Kroft, "I think 30 percent of hospital stays in the United States are probably unnecessary given what our research looks like." [17]

He has published over 150 research articles and commentaries and is a member of the National Academy of Medicine. In 2013 Fisher was named to Modern Healthcare 's list of 50 Most Influential Physician Executives in Healthcare. [18]

Misconduct investigation

Fisher was the director of the Dartmouth Institute for Health Policy but was placed on paid administrative leave in August 2018 following a complaint about conduct in the workplace. In April 2019 the investigation concluded; he was demoted from institute director and no longer holds the John E. Wennberg Distinguished Chair in Health Policy. [19] He returned to active faculty status to pursue research, education, and service.

Related Research Articles

Prescription drug list prices in the United States continually rank among the highest in the world. The high cost of prescription drugs became a major topic of discussion in the 21st century, leading up to the American health care reform debate of 2009, and received renewed attention in 2015. One major reason for high prescription drug prices in the United States relative to other countries is the inability of government-granted monopolies in the American health care sector to use their bargaining power to negotiate lower prices, and the American payer ends up subsidizing the world's R&D spending on drugs.

<span class="mw-page-title-main">Mark McClellan</span> American health economist (born 1963)

Mark Barr McClellan is the director of the Robert J Margolis Center for Health Policy and the Margolis Professor of Business, Medicine and Health Policy at Duke University. Formerly, he was a senior fellow and director of the Health Care Innovation and Value Initiative at the Engelberg Center for Health Care Reform at The Brookings Institution, in Washington, D.C. McClellan served as commissioner of the United States Food and Drug Administration under President George W. Bush from 2002 through 2004, and subsequently as administrator of the Centers for Medicare and Medicaid Services from 2004 through 2006.

<span class="mw-page-title-main">Population health</span> Health outcomes of a group of individuals

Population health has been defined as "the health outcomes of a group of individuals, including the distribution of such outcomes within the group". It is an approach to health that aims to improve the health of an entire human population. It has been described as consisting of three components. These are "health outcomes, patterns of health determinants, and policies and interventions".

Fee-for-service (FFS) is a payment model where services are unbundled and paid for separately.

<span class="mw-page-title-main">Medicare for All Act</span> Proposed U.S. healthcare reform legislation

The Medicare for All Act, aka the Expanded and Improved Medicare for All Act or United States National Health Care Act, is a bill first introduced in the United States House of Representatives by Representative John Conyers (D-MI) in 2003, with 38 co-sponsors. In 2019, the original 16-year-old proposal was renumbered, and Pramila Jayapal (D-WA) introduced a broadly similar, but more detailed, bill, HR 1384, in the 116th Congress. As of November 3, 2019, it had 116 co-sponsors still in the House at the time, or 49.8% of House Democrats.

Consumer-driven healthcare (CDHC), or consumer-driven health plans (CDHP) refers to a type of health insurance plan that allows employers and/or employees to utilize pretax money to help pay for medical expenses not covered by their health plan. These plans are linked to health savings accounts (HSAs), health reimbursement accounts (HRAs), or similar medical payment accounts. Users keep any unused balance or "rollover" at the end of the year to increase future balances or to invest for future expenses. They are a high-deductible health plan which has cheaper premiums but higher out of pocket expenses, and as such are seen as a cost effective means for companies to provide health care for their employees.

In the United States, a high-deductible health plan (HDHP) is a health insurance plan with lower premiums and higher deductibles than a traditional health plan. It is intended to incentivize consumer-driven healthcare. Being covered by an HDHP is also a requirement for having a health savings account. Some HDHP plans also offer additional "wellness" benefits, provided before a deductible is paid. High-deductible health plans are a form of catastrophic coverage, intended to cover for catastrophic illnesses. Adoption rates of HDHPs have been growing since their inception in 2004, not only with increasing employer options, but also increasing government options. As of 2016, HDHPs represented 29% of the total covered workers in the United States; however, the impact of such benefit design is not widely understood.

John E. "Jack" Wennberg is the pioneer and leading researcher of unwarranted variation in the healthcare industry. In four decades of work, Wennberg has documented the geographic variation in the healthcare that patients receive in the United States. In 1988, he founded the Center for the Evaluative Clinical Sciences at Dartmouth Medical School to address that unwarranted variation in healthcare.

Healthcare reform in the United States has a long history. Reforms have often been proposed but have rarely been accomplished. In 2010, landmark reform was passed through two federal statutes: the Patient Protection and Affordable Care Act (PPACA), signed March 23, 2010, and the Health Care and Education Reconciliation Act of 2010, which amended the PPACA and became law on March 30, 2010.

Health information technology (HIT) is health technology, particularly information technology, applied to health and health care. It supports health information management across computerized systems and the secure exchange of health information between consumers, providers, payers, and quality monitors. Based on a 2008 report on a small series of studies conducted at four sites that provide ambulatory care – three U.S. medical centers and one in the Netherlands, the use of electronic health records (EHRs) was viewed as the most promising tool for improving the overall quality, safety and efficiency of the health delivery system.

Bundled payment is the reimbursement of health care providers "on the basis of expected costs for clinically-defined episodes of care." It has been described as "a middle ground" between fee-for-service reimbursement and capitation, given that risk is shared between payer and provider. Bundled payments have been proposed in the health care reform debate in the United States as a strategy for reducing health care costs, especially during the Obama administration (2009–2016). Commercial payers have shown interest in bundled payments in order to reduce costs. In 2012, it was estimated that approximately one-third of the United States healthcare reimbursement used bundled methodology.

Healthcare in the United States is subject to far higher levels of spending than any other nation, measured both in per capita spending and as a percentage of GDP. Despite this, the country has significantly worse healthcare outcomes when compared to peer nations. The U.S. is the only developed nation without a system of universal healthcare, with a significant proportion of its population not carrying health insurance.

An accountable care organization (ACO) is a healthcare organization that ties provider reimbursements to quality metrics and reductions in the cost of care. ACOs in the United States are formed from a group of coordinated health-care practitioners. They use alternative payment models, normally, capitation. The organization is accountable to patients and third-party payers for the quality, appropriateness and efficiency of the health care provided. According to the Centers for Medicare and Medicaid Services, an ACO is "an organization of health care practitioners that agrees to be accountable for the quality, cost, and overall care of Medicare beneficiaries who are enrolled in the traditional fee-for-service program who are assigned to it".

Joseph P. Newhouse is an American economist and the John D. MacArthur Professor of Health Policy and Management at Harvard University, as well as the Director of the Division of Health Policy Research and of the Interfaculty Initiative on Health Policy. At Harvard, he is a member of the four faculties at Harvard Kennedy School in Cambridge, Harvard Medical School in Boston, Harvard T.H. Chan School of Public Health in Boston, and Harvard Faculty of Arts and Sciences in Cambridge.

The Center for Medicare and Medicaid Innovation is an organization of the United States government under the Centers for Medicare and Medicaid Services (CMS). It was created by the Patient Protection and Affordable Care Act, the 2010 U.S. health care reform legislation. CMS provides healthcare coverage to more than 100 million Americans through Medicare, Medicaid, the Children’s Health Insurance Program (CHIP), and the Health Insurance Marketplace.

Unnecessary health care is health care provided with a higher volume or cost than is appropriate. In the United States, where health care costs are the highest as a percentage of GDP, overuse was the predominant factor in its expense, accounting for about a third of its health care spending in 2012.

Balance billing, sometimes called surprise billing, is a medical bill from a healthcare provider billing a patient for the difference between the total cost of services being charged and the amount the insurance pays. It is a pervasive problem in the United States with providers who are out of network, and therefore not subject to the rates or terms of providers who are in-network. Balance billing has a variable prevalence by market and specialty.

<span class="mw-page-title-main">Peter Bach</span> Medical researcher

Peter B. Bach is a physician and writer at Memorial Sloan-Kettering Cancer Center where he is Director of the Center for Health Policy and Outcomes. His research focuses on healthcare policy, particularly as it relates to Medicare, racial disparities in cancer care quality, and lung cancer. Along with his scientific writings he is a frequent contributor to The New York Times and other newspapers.

Dan Mendelson is an American businessman and healthcare consultant who founded Avalere Health, a Washington, D.C.-based strategic advisory company, after serving in the Clinton White House. His opinions have been cited in The New York Times,The Wall Street Journal, National Public Radio, and Bloomberg, among other news outlets. He is the author of numerous papers and several editorials.

The Oncology Care Model (OCM) is an episode-based payment system developed by the Center for Medicare and Medicaid Innovation. The multipayer model is designed for discrete instances of care, especially those involving chemotherapy, which triggers the six-month episode. The program combines fee-for-service (FFS) payments for established services, monthly payments for additional care under a structured guideline, and performance-based payments weighed against quality metrics and benchmarks.

References

  1. ↑ Meyer, Harris (August 3, 2018). "Dartmouth suspends policy researcher Dr. Elliott Fisher". Modern Healthcare. Retrieved July 31, 2019.
  2. ↑ "Dr. Elliot Fisher named new director of Dartmouth Institute for Health Policy & Clinical Practice". Modern Healthcare. Retrieved 2017-03-17.
  3. ↑ Fisher, E. S.; Whaley, F. S.; Krushat, W. M.; Malenka, D. J.; Fleming, C.; Baron, J. A.; Hsia, D. C. (1992-02-01). "The accuracy of Medicare's hospital claims data: progress has been made, but problems remain". American Journal of Public Health. 82 (2): 243–248. doi:10.2105/ajph.82.2.243. ISSN   0090-0036. PMC   1694279 . PMID   1739155.
  4. ↑ Gawande, Atul (2009-06-01). "The Cost Conundrum". The New Yorker. ISSN   0028-792X . Retrieved 2017-03-17.
  5. ↑ "Obamacare's Cost Scalpel". Bloomberg.com. 2010-03-25. Retrieved 2017-03-17.
  6. ↑ Orszag, Peter R. (2014-09-30). "Patient Health Doesn't Explain Cost Differences". Bloomberg View. Retrieved 2017-03-17.
  7. ↑ Sirovich, Brenda; Gallagher, Patricia M.; Wennberg, David E.; Fisher, Elliott S. (2008-05-01). "Discretionary Decision Making By Primary Care Physicians And The Cost Of U.S. Health Care". Health Affairs. 27 (3): 813–823. doi:10.1377/hlthaff.27.3.813. PMC   2438037 . PMID   18474975.
  8. ↑ Barnato, Amber E.; Herndon, M. Brooke; Anthony, Denise L.; Gallagher, Patricia M.; Skinner, Jonathan S.; Bynum, Julie P. W.; Fisher, Elliott S. (2017-03-20). "Are Regional Variations in End-of-Life Care Intensity Explained by Patient Preferences?". Medical Care. 45 (5): 386–393. doi:10.1097/01.mlr.0000255248.79308.41. PMC   2147061 . PMID   17446824.
  9. ↑ Fisher, Elliott S. (2003-02-18). "The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care". Annals of Internal Medicine. 138 (4): 273–87. doi: 10.7326/0003-4819-138-4-200302180-00006 . PMID   12585825.
  10. ↑ "Accountable Care Organization (ACO) | Nalari". www.nalarihealth.com. Retrieved 2017-03-17.
  11. ↑ Fisher, Elliott S.; Staiger, Douglas O.; Bynum, Julie P. W.; Gottlieb, Daniel J. (2007-01-01). "Creating Accountable Care Organizations: The Extended Hospital Medical Staff". Health Affairs. 26 (1): w44–w57. doi:10.1377/hlthaff.26.1.w44. PMC   2131738 . PMID   17148490.
  12. ↑ Fisher, Elliott S.; McClellan, Mark B.; Bertko, John; Lieberman, Steven M.; Lee, Julie J.; Lewis, Julie L.; Skinner, Jonathan S. (2009-03-01). "Fostering accountable health care: moving forward in medicare". Health Affairs. 28 (2): w219–231. doi:10.1377/hlthaff.28.2.w219. PMC   2656392 . PMID   19174383.
  13. ↑ "Accountable Care Organizations, Explained". NPR.org. Retrieved 2017-03-20.
  14. ↑ "The Pioneers | ReThink Health". www.rethinkhealth.org. Retrieved 2017-03-20.
  15. ↑ "Accelerating Health System Transformation By Disrupting The Status Quo". Health Affairs. 2016. doi:10.1377/forefront.20161208.057862.
  16. ↑ "Berkeley center part of 5-year $17.5 million collaborative effort to spur innovation in health care". UC Berkeley School of Public Health. 2015-06-17. Retrieved 2017-03-20.
  17. ↑ "The Cost of Dying". 60 Minutes. CBS News. November 19, 2009. Retrieved 2017-03-17.
  18. ↑ "Modern Healthcare | The leader in healthcare business news, research & data". Modern Healthcare. 16 April 2013. Retrieved 2017-03-17.
  19. ↑ "College completes misconduct investigation". Valley News.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.